Author: Lu Guo; Xuehan Sun; Xinge Wang; Chen Liang; Haiping Jiang; Qingqin Gao; Moyu Dai; Bin Qu; Sen Fang; Yihuan Mao; Yangcan Chen; Guihai Feng; Qi Gu; Liu Wang; Ruiqi Rachel Wang; Qi Zhou; Wei Li
Title: SARS-CoV-2 detection with CRISPR diagnostics Document date: 2020_4_11
ID: 2una9767_3
Snippet: The novel coronavirus (CoV) disease termed caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) [1] is causing a massive pandemic worldwide, threatening public health systems across the globe. During this ongoing COVID-19 outbreak, nucleic acid detection has played an important role in early diagnosis [2] . To date, 4 protocols based on CRISPR for detecting SARS-CoV-2 have been published [3] [4] [5] [6] . Using lateral flow prot.....
Document: The novel coronavirus (CoV) disease termed caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) [1] is causing a massive pandemic worldwide, threatening public health systems across the globe. During this ongoing COVID-19 outbreak, nucleic acid detection has played an important role in early diagnosis [2] . To date, 4 protocols based on CRISPR for detecting SARS-CoV-2 have been published [3] [4] [5] [6] . Using lateral flow protocols, RNA samples harboring more than 1 × 10 4 -1 × 10 5 copies/mL (SHERLOCK) or 1 × 10 4 copies/mL (DETECTR) can be detected within 1 hour. In addition to these reported efforts, we have also established a SARS-CoV-2 detection protocol based on our previously reported platform -CDetection (Cas12b-mediated DNA detection) [7] . By combining sample treatment protocols and nucleic acid amplification methods with CDetection, we have established an integrated viral nucleic acid detection platform -CASdetec (CRISPR-assisted detection). The detection limit of CASdetec for SARS-CoV-2 pseudovirus is 1 × 10 4 copies/mL, with no cross reactivity observed. Here we present our assay design and optimization process, which could provide guidance for future CRISPR-based nucleic acid detection assay development and optimization.
Search related documents:
Co phrase search for related documents- amplification method and cross reactivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- amplification method and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- amplification method and dna detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- amplification method and early diagnosis: 1, 2, 3, 4, 5, 6, 7
- amplification method and important role: 1
- amplification method and massive pandemic: 1, 2
- amplification method and nucleic acid detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- amplification method and nucleic acid detection platform: 1
- amplification method and ongoing outbreak: 1
- amplification method and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amplification method and RNA sample: 1, 2, 3, 4, 5, 6
- amplification method and SARS detect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- amplification method and SARS detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- amplification method and SARS Severe Acute Respiratory Syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- amplification method and Severe Acute Respiratory Syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- assay development and CASdetec detection limit: 1, 2
- assay development and cross reactivity: 1, 2, 3, 4, 5, 6, 7, 8
- assay development and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- assay development and dna detection: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date